Scholars Central

Conference abstractPublished 14 Nov 2022

Role of probiotics and prebiotics in the management of gastrointestinal disorders from SARS-CoV-2 and bacterial secondary infections

Authors: Shyamapada Mandal

Department of Zoology, University of Gour Banga, India.

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

The COVID-19, caused with the infection of SARS-CoV-2, has been a pandemic since December 2019. The virus, SARS-CoV-2, primarily infects lungs, and also causes dysbiosis of the gut microbiota, leading to the disruption of immune homeostasis (by invading gut epithelium using angiotensin-converting enzyme 2), thereby facilitating bacterial secondary infections causing gastrointestinal disorders. These events lead to a condition called blood-brain-barrier (BBB) dysfunction, which causes inflammation of the brain, and leads to severe and/or prolonged COVID-19. Prebiotics (including those derived from plant sources) —the components that enhance the viability and functionality of probiotics (in the gut),— act synbiotically thereby restoring the gut homeostasis and the BBB functionality as well, through gut-microbiota-brain axis. Thus, COVID-19 and the associated bacterial secondary infections causing gastrointestinal disorders might be prevented with probiotics as well as prebiotics supplementations

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • SubjectMicrobiology
  • SubjectGastroenterology & Hepatology
  • SubjectInfectious Diseases
  • BylineArticles whose byline prints “Shyamapada Mandal”